Generation Bio (GBIO) Enterprise Value (2021 - 2025)
Historic Enterprise Value for Generation Bio (GBIO) over the last 5 years, with Q3 2025 value amounting to -$89.6 million.
- Generation Bio's Enterprise Value rose 5149.54% to -$89.6 million in Q3 2025 from the same period last year, while for Sep 2025 it was -$89.6 million, marking a year-over-year increase of 5149.54%. This contributed to the annual value of -$185.2 million for FY2024, which is 2993.64% up from last year.
- Generation Bio's Enterprise Value amounted to -$89.6 million in Q3 2025, which was up 5149.54% from -$141.4 million recorded in Q2 2025.
- In the past 5 years, Generation Bio's Enterprise Value ranged from a high of -$37.7 million in Q1 2024 and a low of -$451.1 million during Q1 2021
- Its 5-year average for Enterprise Value is -$265.8 million, with a median of -$288.6 million in 2023.
- In the last 5 years, Generation Bio's Enterprise Value surged by 8693.57% in 2024 and then plummeted by 31781.76% in 2025.
- Generation Bio's Enterprise Value (Quarter) stood at -$375.1 million in 2021, then grew by 25.6% to -$279.1 million in 2022, then rose by 5.28% to -$264.4 million in 2023, then rose by 29.94% to -$185.2 million in 2024, then skyrocketed by 51.61% to -$89.6 million in 2025.
- Its last three reported values are -$89.6 million in Q3 2025, -$141.4 million for Q2 2025, and -$157.6 million during Q1 2025.